ssmuБюллетень сибирской медициныBulletin of Siberian Medicine1682-03631819-3684Siberian State Medical University, the Ministry of Healthcare of the Russian Federation10.20538/1682-0363-2009-1(2)-100-102ssmu-1775Research ArticleСТРАНИЧКА ПРАКТИЧЕСКОГО ВРАЧАTHE PAGE OF PRACTICAL DOCTORРоль некоторых факторов риска в развитии и течении бокового амиотрофического склерозаThe role of some risk factors in the development and the flow of amyotrophic lateral sclerosisЛебедевА. В.LebedevA. V.

Лебедев Антон Викторович, аспирант кафедры неврологии и нейрохирургии 

тел. +7-905-957-34-78

marisha-lebedeva@mail.ruНовосибирский государственный медицинский университетRussian Federation20092802200981(2)100102Copyright © Лебедев А.В., 20092009Лебедев А.В.Lebedev A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://bulletin.ssmu.ru/jour/article/view/1775

On examination of 58 people with accurate amyotrophic lateral sclerosis the role of some risk factors in the development and the character of the flow of the disease was analyzed. The received findings don’t allow excluding the participation of the viruses of herpes and cytomegalovirus in the emergence and development of amyotrophic lateral sclerosis. The particularities of the flow of amyotrophic lateral sclerosis because of the level of specific antibodies of the class G viruses of herpes and cytomegalovirus were not revealed.

боковой амиотрофический склерозфакторы рискаamyotrophic lateral sclerosisrisk factorsReferencesИллариошкин С.Н. Конформационные болезни мозга. М., 2003.Иллариошкин С.Н. Конформационные болезни мозга. М., 2003.Miller R.G., Bradley W.G., Gelinal D.F. et al. Amyotrophic lateral sclerosis//Continuum. 2002. V. 8. № 4. P. 1-227.Miller R.G., Bradley W.G., Gelinal D.F. et al. Amyotrophic lateral sclerosis//Continuum. 2002. V. 8. № 4. P. 1-227.Mitsumoto H., Chad D.A., Pioro E.P. Amyotrophic lateral sclerosis. F.A. Davis Company. Philadelphia 1998. P. 1-480.Mitsumoto H., Chad D.A., Pioro E.P. Amyotrophic lateral sclerosis. F.A. Davis Company. Philadelphia 1998. P. 1-480.Norris F.H. Onset, natural history and prognosis of adult mitir neuron disease//J. Neurol. Sci. 1993. V. 118. P. 48-55.Norris F.H. Onset, natural history and prognosis of adult mitir neuron disease//J. Neurol. Sci. 1993. V. 118. P. 48-55.Vedlink J.H., van den Berg L.H., Wokke J.H.J. The future of motor neuron disease//J. Neurol. 2004. V. 251. P. 491-500.Vedlink J.H., van den Berg L.H., Wokke J.H.J. The future of motor neuron disease//J. Neurol. 2004. V. 251. P. 491-500.Weiss K.M., Terwilliger J.D. How many diseases does it take to map a gene with SNPs?//Nat. Genet. 2000. V. 26. P. 151-157.Weiss K.M., Terwilliger J.D. How many diseases does it take to map a gene with SNPs?//Nat. Genet. 2000. V. 26. P. 151-157.William P.A., Carla J.G. Biological role of interleukin 1 receptor antagonist isoforms//Ann. Rheum. Dis. 2000. V. 59. C. 160-164.William P.A., Carla J.G. Biological role of interleukin 1 receptor antagonist isoforms//Ann. Rheum. Dis. 2000. V. 59. C. 160-164.

The authors declare that there are no conflicts of interest present.